- Original article
- Open Access
Study of diabetes mellitus among patients with hepatitis C virus
The Egyptian Journal of Internal Medicine volume 24, pages 17–23 (2012)
Hepatitis C virus (HCV) infection and type 2 diabetes are two common disorders with high impact on health worldwide. There is growing evidence to support the concept that HCV is associated with type 2 diabetes.
This work aimed to study the clinical phenotype of type 2 diabetes in HCV patients.
Patients and methods
Our study was conducted upon 100 nonobese, noncirrhotic hepatitis C positive patients who were classified into two groups according to homeostatic model assessment (HOMA) test for insulin resistance (HOMA IR). This study also included 15 nonobese type 2 diabetic patients negative for HCV and hepatitis B virus infection classified as control groups. We excluded alcoholics and drug addicts and patients with conditions that affect blood glucose such as endocrine diseases associated with disordered glucose metabolism and use of drugs. All participants were subjected to full history taking and complete clinical examination including BMI and the following investigations: complete blood count, fasting blood sugar, 2 h postprandial blood sugar, glycosylated hemoglobin, fasting insulin level, cholesterol level, HDL, LDL, triglyceride, serum urea, creatinine, complete urine analysis, liver function tests: total bilirubin, alkaline phosphatase, albumin, prothrombin time, INR, SGOT, SGPT, quantitative PCR for determination of HCV-RNA, surface antigen (HbsAg), abdominal ultrasonography, liver biopsy when needed and possible for HCV patients, and ECG.
In this study, we found that the prevalence of type 2 diabetes in group I is 24%. HCV can independently contribute to IR with viral genotypes 1 or 4. We noticed significant positive correlation between fasting insulin and HOMA IR in hepatitis C +ve patients. IR in HCV-infected patients is high irrespective of the degree of liver injury even before a minimal fibrosis is present. Both IR and diabetes can adversely affect the course of chronic hepatitis C, leading to enhanced steatosis and liver fibrosis, and even increase the risk of hepatocellular carcinoma. A significant correlation between HOMA IR and steatosis, a significant positive correlation between fasting insulin and steatosis and a negative correlation between steatosis and BMI in HCV patients was found. No correlation was found between HOMA IR and the viral load (quantitative HCV RNA).
We can concluded that diabetic HCV patients had intermediate clinical phenotype lower BMI and LDL than control and development of type 2 diabetes mellitus in HCV patients was significantly higher in nontreated patients than treated patients. Antiviral therapy and clearance of HCV improves IR, β-cell function, the blood glucose abnormalities.
Albert L, Cristina H, Joan G, et al. Glucose abnormalities with hepatitis C virus infection. Diabetes Care 2006; 29:1140.
Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Goglia F, et al. Hepatitis C virus infection:evidence for an association with type 2 diabetes. Diabetes Care 2005; 28:2548–2550.
Marcin S, Zozuliska D, Juszyk J, et al. Hepatitis C Virus infection:evidence for an association with type2 diabetes. Diabetes care 2006; 29:750.
Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastro-enterology 2002; 122:1649–1657.
Papatheodoridis GV, Chrysanthos N, Savvas S, Sevastianos V, Kafiri G, Petraki K, et al. Diabetes mellitus in chronic hepatitis B and C:prevalence and potential association with the extent of liver fibrosis. J. Viral Hepatitis 2006; 13:303–310.
Miyao M, Shoji M, Shinji A. Decresed plasma adiponectin concentration in wamen with dyslipidemia. J Clin Endoc and Met 2002; 87:2764–2769.
Abraham EG, Blisse E, Gonen E. Glycosylated hemoglobin. Chromatog 1985; 81.
Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment:insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412–419.
Matsubara M, Chiba H, Maruoka S, Katayose S. Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome. J Atherosc Thromb 2000; 7:231–237.
García Pagán JC, Calleja JL, Bañares R. Liver diseases [Enfermedades hepáticas]. Gastroenterol Hepatol 2006; 29 (Suppl 3):99–111.
Desmet GL, Soni A, Quinn PG. Clinical features of hepatitis C infected patients with persistently normal alanine transferase levels in United States. Heoatology 2000; 30:1307.
Thuluvath PJ, John PR. Association between hepatitis C, diabetes mellitus and race:a case-control study. Am J Gastroenterol 2003; 98:438–441.
Wang CS, Wang ST, Yao WJ, Chang TT, Chou P. Community-based study of hepatitis C virus infection and type 2 diabetes:an association affected by age and hepatitis severity status. Am J Epidemiol 2003; 158:1154–1160.
Moriishi K, Mori Y, Matsuura Y. Processing and pathogenicity of HCV core protein. Uirusu J Virol 2008; 58:183–190.
Nagao Y, Kawasaki K, Sata M. Insulin resistance and LP in patients with hepatitis C virus infection liver diseases. J Gastroentrol Hepatol 2008; 23:580–585.
Tsochatzis E, Manolakopoulos S, Papatheodoridis GV, Hadziyannis E, Triantos C, Zisimopoulos K, et al. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C:a multicentre study. Alimen Pharmacol Therap 2009; 30:947–954.
Sougleri M, Labropoulou Karatza C, Paraskevopoulou P, Fragopanagou H, Alexandrides T. Chronic hepatitis C virus infection without cirrhosis induces insulin resistance in patients with β-thalassaemia major. Eur J Gastroenterol Hepatol 2001; 13:1195–1199.
Skowroski M, Zozuli D, Juszczyk D, et al. Hepatitis C virus infection:evidence for an association with Type 2 diabetes. Diabetes Care 2006; 29:750.
Björnsson E, Angulo P. Hepatitis C and steatosis. Arch Med Res 2007; 38:621–627.
Jason M. Insulin is associated with chronic hepatitis C virus infection fibrosis progression. Gastoentrol 2003; 2:125.
Moucari R, Asselah T, Cazals Hatem D, Voitot H, Boyer N, Ripault M, et al. Insulin resistance in chronic hepatitis C:association with genotypes 1 and 4, serum HCV RNA level and liver fibrosis. Gastroenterology 2008; 134:416–423.
Machado MV, Cortez Pinto H. Insulin resistance and steatosis in chronic hepatitis C. Ann Hepatol 2009; 8 (Suppl. 1):S67–S75.
Negro F, Alaei M. Hepatitis C virus and type 2 diabetes. World J Gastro-enterol 2009; 15:1537–1547.
Merchante N, Macías J, Ramayo E, Vergara S, García García JA, Mira JA, et al. Insulin resistance is not associated with liver fibrosis progression in HIV/ hepatitis C virus-coinfected patients. J Viral Hepatitis 2006; 13:449–456.
Antonelli A, Ferri C, Fallahi P, Sebastiani M, Nesti C, Barani L, et al. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology 2004; 43:238–240.
Lecube A, Hernández C, Genescà J, Simó R. Proinflammatory cytokines, insulin resistance and insulin secretion in chronic hepatitis C patients:a case-control study. Diabetes Care 2006; 29:1096–1101.
Castera L, Chouteau P, Hezode C, Zafrani ES, Dhumeaux D, Pawlotsky JM. Hepatitis C virus-induced hepatocellular steatosis. Am J Gastroenterol 2005; 100:711–715.
Kawaguchi T, Ide T, Taniguchi E, Hirano E, Itou M, Sumie S, et al. Clearance of HCV improves insulin resistance, beta-cell function and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol 2007; 102:570–576.
Simó R, Lecube A, Genescà J, Esteban JI, Hernández C. Sustained vir-ological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diabetes Care 2006; 29:2462–2466.
Azócar J. Adult onset diabetes mellitus in hepatitis C virus infection. 2003; Available at: mailto:email@example.com.
Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, DePinho RA, et al. Medicine:the kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005; 310:1642–1646.
About this article
Cite this article
Raouf, M.A., Yousry, Z.A., Hindy, O.M. et al. Study of diabetes mellitus among patients with hepatitis C virus. Egypt J Intern Med 24, 17–23 (2012). https://doi.org/10.7123/01.EJIM.0000415588.62804.fc
- hepatitis C virus
- insulin resistance
- type 2 diabetes mellitus